|
Unaudited interim results for the six months ended 30 June 2025
AfroCentric Investment Corporation Limited
(Incorporated in the Republic of South Africa)
(Registration number 1988/000570/06)
JSE Code: ACT ISIN: ZAE000078416
("AfroCentric" or "the Company")
Unaudited interim results for the six months ended 30 June 2025
Introduction to the AfroCentric Group
AfroCentric is a BEE level 1, JSE listed investment holding company, committed to transforming and
advancing healthcare access and affordability across Southern Africa. Through our diversified portfolio of
subsidiaries, we deliver integrated health management solutions, including medical aid administration,
managed care, medicine provision, wellness services and digital health innovations. The Group plays a
pivotal role across the public and private sectors, driving efficiencies, health outcomes and enabling
sustainable healthcare delivery. Our strategic focus remains on expanding our footprint, leveraging
technology and clinical innovation, and fostering partnerships that support inclusive, value-based
healthcare for all.
The Board presents a summary of the Company's results for the six months ending 30 June 2025.
Salient Features
% Six months Six months
change ended 30 June ended 30
2025 June 2024
Revenue from contracts with customers (R' million) – (2.6) 4 211.1 4 322.9
continuing operations
Profit/(loss) before tax (R' million) – continuing operations 298.4 161.0 (81.2)
Profit/(loss) from continuing operations (R' million) 183.4 108.1 (129.6)
(Loss)/profit from discontinued operations (R' million) (107.4) (1.4) 18.8
Basic earnings/(loss) (R' million) 182.0 97.1 (118.4)
Headline earnings (R' million) (37.8) 98.2 157.8
Basic earnings/(loss) (cents per share) 180.9 11.54 (14.26)
Headline earnings (cents per share) (38.5) 11.68 19.00
Weighted average number of ordinary shares 840.99 million 830.32 million
Dividend declared (cents per share) - -
Full Announcement
This short-form announcement is the responsibility of the Directors of the Company and is a summary of
the information in the full announcement and does not contain full or complete details. The full
announcement is available for viewing on the following websites:
Company's website: http://www.afrocentric.za.com/investor-centre/
JSE website: https://senspdf.jse.co.za/documents/2025/JSE/ISSE/ACT/Jun2025.pdf.
Management will host a virtual investor presentation tomorrow, Wednesday, 03 September 2025 at 10:00
SAST. The webcast will be accessible at http://www.acinterim2025.co.za
This short-form announcement does not contain full or complete details and any investment decision by
investors and/or shareholders should be based on consideration of the information contained in the
summarised results for the six months ended 30 June 2025. Copies of which are also available for inspection
at the Company's offices on workdays during business hours (at no charge) or on request from the company
secretary by email: lebohang.mpumlwana@afrocentrichealth.com
On behalf of the Board
Dr ATM Mokgokong Mr GN van Wyk
Chairman Group Chief Executive Officer
Johannesburg
2 September 2025
JSE Sponsor to AfroCentric
Questco Corporate Advisory Proprietary Limited
Date: 02-09-2025 09:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS. |
|
